Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)
CIMA — Centro de Información de Medicamentos · Spain
- Updated
- Not provided for this source record
- Synchronized
- Oct 2, 2026
Medicine · Spain
ULTRA-LEVURA 250 MG POLVO PARA SUSPENSION ORAL
Suspension
Home Med Cabinet
Updated · Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) — Not provided for this source record
Synchronized
At a glance
- Active ingredient
- SACCHAROMYCES BOULARDII CNCM I-745 — 250 mg
- Pharmaceutical form Home Med Cabinet grouping
- Suspension
- Availability in Spain
- All 2 packs marketed
Packs
ULTRA-LEVURA 250 MG POLVO PARA SUSPENSION ORAL, 10 sobres
10 pcs
National code
Marketed725443Strength of this pack 250 mg
ULTRA-LEVURA 250 MG POLVO PARA SUSPENSION ORAL, 20 sobres
20 pcs
National code
Marketed725574Strength of this pack 250 mg
“Marketed” means the authority records the pack as placed on the market. It is not a statement about pharmacy stock.
Official documents
Documents open on the authority’s own site. Home Med Cabinet links to them and hosts no copy.
No official document link is published here
The authority publishes no document for this medicine.
Registration
- Registration number
- 2123-13-1-2010Official data
- Marketing authorisation holder
- PETSIAVAS S.A. INDUSTRIAL AND COMMERCIAL ENTERPRISESOfficial data
- Authorised
- Apr 24, 2019Official data
- Authority form code
- 9Official data
Classification
ATC classification is not published here yet
Publication rights for ATC codes and labels are still under review, and no classification is inferred for this record.